FDA NDC Directory · JSON-LD · Markdown

COXANTO

NDC 70512-814 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameoxaprozin
Labeler / ManufacturerSOLA Pharmaceuticals, LLC
Marketing categoryNew Drug Application (innovator) · App NDA217927
Dosage form / routeCAPSULE · ORAL
Active ingredientsOXAPROZIN (300 mg/1)
Marketing started20251103
Package count1

External sources

Source: openFDA. Public-domain (CC0).